Published in J Rheumatol on May 01, 1995
A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford) (2012) 3.56
Psoriasis treatment: current and emerging directed therapies. Ann Rheum Dis (2005) 1.56
Development of the PsAQoL: a quality of life instrument specific to psoriatic arthritis. Ann Rheum Dis (2004) 1.46
Survival of TNF antagonists in spondylarthritis is better than in rheumatoid arthritis. Data from the Spanish registry BIOBADASER. Arthritis Res Ther (2006) 1.37
Psoriatic arthritis therapy: NSAIDs and traditional DMARDs. Ann Rheum Dis (2005) 1.17
Managing patients with psoriatic disease: the diagnosis and pharmacologic treatment of psoriatic arthritis in patients with psoriasis. Drugs (2014) 1.00
Treating psoriatic arthritis: how effective are TNF antagonists? Arthritis Res Ther (2004) 0.83
N08C9 (Alliance): A Phase 3 Randomized Study of Sulfasalazine Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy. Int J Radiat Oncol Biol Phys (2016) 0.78
Sulfasalazine: a definitively efficient treatment for psoriatic arthritis. J Rheumatol (1996) 0.77
Clinical and demographic characteristics of patients with psoriatic arthritis in northern Israel. Rheumatol Int (2010) 0.77
Integrated Drug Expression Analysis for leukemia: an integrated in silico and in vivo approach to drug discovery. Pharmacogenomics J (2016) 0.76
Psoriatic arthritis: latest treatments and their place in therapy. Ther Adv Chronic Dis (2015) 0.76
[Psoriatric arthritis - a permanent challenge for rheumatologists and patients: part 2: imaging diagnostics, classification and therapy]. Z Rheumatol (2011) 0.75
[Psoriatic arthritis]. Wien Med Wochenschr (2006) 0.75
The cell biology of macrophage activation. Annu Rev Immunol (1984) 7.27
Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med (1997) 4.57
Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature (1996) 3.83
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid) N Engl J Med (1993) 3.06
Characterization of intercellular adhesion molecule-1 and HLA-DR expression in normal and inflamed skin: modulation by recombinant gamma interferon and tumor necrosis factor. J Am Acad Dermatol (1989) 2.77
Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2, and prostaglandin F2alpha in epidermis of psoriasis. Proc Natl Acad Sci U S A (1975) 2.75
Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP-1 in experimental autoimmune encephalomyelitis. FASEB J (1993) 2.69
Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial. N Engl J Med (1991) 2.66
Overexpression of transforming growth factor alpha in psoriatic epidermis. Science (1989) 2.63
Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum Mol Genet (1997) 2.48
Molecular transductional mechanisms by which IFN gamma and other signals regulate macrophage development. Immunol Rev (1987) 2.37
Thrombosis in patients with connective tissue diseases treated with specific cyclooxygenase 2 inhibitors. A report of four cases. Arthritis Rheum (2000) 2.26
Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16
Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in black patients. N Engl J Med (1993) 2.15
Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol (1999) 2.11
A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol (1992) 2.11
Linkage analysis of human leukocyte antigen (HLA) markers in familial psoriasis: strong disequilibrium effects provide evidence for a major determinant in the HLA-B/-C region. Am J Hum Genet (1998) 2.09
Comparison of CD271 (adapalene) and all-trans retinoic acid in human skin: dissociation of epidermal effects and CRABP-II mRNA expression. J Invest Dermatol (1993) 2.07
Pruritus associated with nocturnal wakenings: organic or psychogenic? J Am Acad Dermatol (1989) 2.06
Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem (1997) 2.05
T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Cancer Res (1993) 1.98
A chemokine-to-cytokine-to-chemokine cascade critical in antiviral defense. J Clin Invest (2000) 1.97
Vitamin A antagonizes decreased cell growth and elevated collagen-degrading matrix metalloproteinases and stimulates collagen accumulation in naturally aged human skin. J Invest Dermatol (2000) 1.97
Cyclosporine improves psoriasis in a double-blind study. JAMA (1986) 1.95
Identification of transferrin receptors on the surface of human cultured cells. Proc Natl Acad Sci U S A (1979) 1.93
The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol (2000) 1.91
Cooperative interaction between interferon (IFN) stimulus response element and kappa B sequence motifs controls IFN gamma- and lipopolysaccharide-stimulated transcription from the murine IP-10 promoter. J Biol Chem (1993) 1.88
Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet (2000) 1.86
Decreased Ras-mitogen-activated protein kinase signaling may cause DNA hypomethylation in T lymphocytes from lupus patients. Arthritis Rheum (2001) 1.84
The genetics of psoriasis. Arch Dermatol (1994) 1.84
The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J Immunol (1995) 1.83
Psoralen plus black light inhibits epidermal DNA synthesis. Arch Dermatol (1973) 1.75
The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol (1998) 1.72
Interferon-gamma modulates protein kinase C activity in murine peritoneal macrophages. J Biol Chem (1985) 1.71
Molecular mechanisms of retinoid actions in skin. FASEB J (1996) 1.69
Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis. N Engl J Med (1990) 1.68
Comparison of human alkaline phosphatase isoenzymes. Structural evidence for three protein classes. Biochem J (1979) 1.68
Requirement for STAT1 in LPS-induced gene expression in macrophages. J Leukoc Biol (2001) 1.68
A macrophage LPS-inducible early gene encodes the murine homologue of IP-10. Biochem Biophys Res Commun (1990) 1.66
Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. J Immunol (1989) 1.65
Topical tretinoin improves photoaged skin. A double-blind vehicle-controlled study. JAMA (1988) 1.65
Alcohol intake and treatment responsiveness of psoriasis: a prospective study. J Am Acad Dermatol (1993) 1.60
Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol (1995) 1.60
Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med (1999) 1.56
Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest (1998) 1.55
Sulfasalazine improves psoriasis. A double-blind analysis. Arch Dermatol (1990) 1.53
UV exposure reduces immunization rates and promotes tolerance to epicutaneous antigens in humans: relationship to dose, CD1a-DR+ epidermal macrophage induction, and Langerhans cell depletion. Proc Natl Acad Sci U S A (1992) 1.52
Oral cyclosporine for severe chronic idiopathic urticaria and angioedema. J Am Acad Dermatol (1991) 1.52
A morphometric and histologic study of the scalp in psoriasis. Paradoxical sebaceous gland atrophy and decreased hair shaft diameters without alopecia. Arch Dermatol (1989) 1.51
Ciclosporin in psoriasis clinical practice: an international consensus statement. Br J Dermatol (2004) 1.51
Cyclosporine in dermatology. J Am Acad Dermatol (1989) 1.50
c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest (2000) 1.50
The effect of LPS on expression of the early "competence" genes JE and KC in murine peritoneal macrophages. J Immunol (1987) 1.50
Molecular mechanisms of nonablative fractionated laser resurfacing. Br J Dermatol (2010) 1.47
The role of methotrexate in the management of steroid-dependent asthma. Chest (1994) 1.46
Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol (1996) 1.45
Behçet's disease. Int J Dermatol (1984) 1.45
Autoimmunity to collagen in adjuvant arthritis of rats. J Clin Invest (1980) 1.44
Bulimia nervosa and acne may be related: a case report. Can J Psychiatry (1992) 1.44
Molecular mechanisms of photoaging and its prevention by retinoic acid: ultraviolet irradiation induces MAP kinase signal transduction cascades that induce Ap-1-regulated matrix metalloproteinases that degrade human skin in vivo. J Investig Dermatol Symp Proc (1998) 1.43
Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol (2001) 1.42
Inocoterone and acne. The effect of a topical antiandrogen: results of a multicenter clinical trial. Arch Dermatol (1992) 1.41
Cyclosporine in the treatment of psoriatic arthritis. Arch Dermatol (1989) 1.41
Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A. Infect Immun (1993) 1.41
Stratification, specialization, and proliferation of primary keratinocyte cultures. Evidence of a functioning in vitro epidermal cell system. J Cell Biol (1978) 1.40
Monokine induced by IFN-gamma is a dominant factor directing T cells into murine cardiac allografts during acute rejection. J Immunol (2001) 1.40
A pilot study of the effect of oral 8-methoxypsoralen and intraarticular ultraviolet light on rheumatoid synovitis. J Rheumatol (1995) 1.40
Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy. Arch Dermatol (1995) 1.40
Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. Arch Dermatol (1994) 1.39
Sulfasalazine: a potential psoriasis therapy? J Am Acad Dermatol (1989) 1.39
IL-1 activity is reduced in psoriatic skin. Decreased IL-1 alpha and increased nonfunctional IL-1 beta. J Immunol (1990) 1.39
Lymphocytic infiltrates of the skin in association with cyclosporine therapy. J Am Acad Dermatol (1990) 1.39